Fate Therapeutics Overview
Fate Therapeutics Discounted Cash Flow
DCF Analysis for FATE.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.52
Current Fair Value
$-0.52
↓ 125.9% Downside
Overvalued by 125.9% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison